INTRAPERITONEAL PACLITAXEL

Clinical trials for INTRAPERITONEAL PACLITAXEL explained in plain language.

Never miss a new study

Get alerted when new INTRAPERITONEAL PACLITAXEL trials appear

Sign up with your email to follow new studies for INTRAPERITONEAL PACLITAXEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New chemo delivery method tested for rare abdominal cancer

Disease control Recruiting now

This early-phase study is testing a new way to give the chemotherapy drug paclitaxel directly into the abdominal cavity for patients with advanced appendix cancer that has spread. The goal is to find a safe and effective dose and see if this direct delivery can shrink tumors and …

Matched conditions: INTRAPERITONEAL PACLITAXEL

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

INTRAPERITONEAL PACLITAXEL

Get alerted when new INTRAPERITONEAL PACLITAXEL trials appear

New chemo delivery method tested for rare abdominal cancer